What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook.
23hon MSN
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%
Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo! Finance) implies a significant 131% upside from its current levels. And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback